기준가
$69.28
운용 규모
$3.1B
보수율
-
배당수익률
4.31%
베타
0.57
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +6.31% | +7.74% | +12.54% | +21.74% | +8.95% | +5.78% |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 15.81% |
| 2 | JNJ | Johnson & Johnson | 9.68% |
| 3 | ABBV | AbbVie Inc | 6.89% |
| 4 | UNH | UnitedHealth Group Inc | 6.18% |
| 5 | MRK | Merck & Co Inc | 5.27% |
| 6 | TMO | Thermo Fisher Scientific Inc | 3.32% |
| 7 | AMGN | Amgen Inc | 3.24% |
| 8 | GILD | Gilead Sciences Inc | 2.99% |
| 9 | ISRG | Intuitive Surgical Inc | 2.68% |
| 10 | PFE | Pfizer Inc | 2.66% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
설정일: 2000-06-12